Should we abandon the use of prophylactic PD stents to prevent post-ERCP pancreatitis?

Am J Gastroenterol. 2014 Aug;109(8):1292. doi: 10.1038/ajg.2014.160.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Cholangiopancreatography, Endoscopic Retrograde / adverse effects*
  • Humans
  • Indomethacin / therapeutic use*
  • Nitrates / therapeutic use*
  • Pancreatitis / prevention & control*

Substances

  • Nitrates
  • Indomethacin